T 0562/20 (Mutant ALK kinase in human solid tumors/CELL SIGNALING TECHNOLOGY) of 19.10.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T056220.20221019
- Date of decision
- 19 October 2022
- Case number
- T 0562/20
- Petition for review of
- -
- Application number
- 12150524.2
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Gene defects and mutant ALK kinase in human solid tumors
- Applicant name
- Cell Signaling Technology, Inc.
- Opponent name
- F. Hoffmann-La Roche AG
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(1)European Patent Convention Art 123(2)European Patent Convention Art 84European Patent Convention R 106Rules of procedure of the Boards of Appeal Art 12(4)Rules of procedure of the Boards of Appeal Art 13
- Keywords
- Main request - admitted- clarity (no)
Auxiliary request 1 - admitted - added subject- matter (yes)
Auxiliary request 2 - admitted into the proceedings (no)
Obligation to raise objections - objection dismissed - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The objection under Rule 106 EPC is dismissed.
2. The appeal is dismissed.